Document is current
Any future updates will be listed below
-
Authors
Peng, Ye https://orcid.org/0000-0003-3791-2305
Zhang, Lin
Mok, Chris K. P.
Ching, Jessica Y. L.
Zhao, Shilin
Wong, Matthew K. L.
Zhu, Jie
Chen, Chunke
Wang, Shilan
Yan, Shuai
Qin, Biyan
Liu, Yingzhi
Zhang, Xi https://orcid.org/0000-0003-1340-7128
Cheung, Chun Pun
Cheong, Pui Kuan
Ip, Ka Long
Fung, Adrian C. H.
Wong, Kenneth K. Y.
Hui, David S. C.
Chan, Francis K. L.
Ng, Siew C.
Tun, Hein M. https://orcid.org/0000-0001-7597-5062
-
Funding
Funding for this research was provided by:
Chinese University of Hong Kong
National Research Foundation of Korea
Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (COVID193002)
- License Information
-
More Information
Article History
Received: 22 May 2023
Revised: 22 August 2023
Accepted: 25 August 2023
First Online: 25 September 2023
Competing interests
: F.K.L.C. is Board Member of CUHK Medical Centre. He is a co-founder, non-executive Board Chairman and shareholder of GenieBiome Ltd. He receives patent royalties through his affiliated institutions. He has received fees as an advisor and honoraria as a speaker for Eisai Co. Ltd., AstraZeneca, Pfizer Inc., Takeda Pharmaceutical Co., and Takeda (China) Holdings Co. Ltd. S.C.N. has served as an advisory board member for Pfizer, Ferring, Janssen, and Abbvie and received honoraria as a speaker for Ferring, Tillotts, Menarini, Janssen, Abbvie, and Takeda. S.C.N. has received research grants through her affiliated institutions from Olympus, Ferring, and Abbvie. S.C.N. is a founder member, non-executive director, non-executive scientific advisor, and shareholder of GenieBiome Ltd. S.C.N. receives patent royalties through her affiliated institutions. F.K.L.C., S.C.N., L.Z., and H.M.T. are named inventors of patent applications held by the CUHK and MagIC that cover the therapeutic and diagnostic use of microbiome.
